ASPEN PHARMACARE HOLDINGS LIMITED - Aspen, CEPI and the Bill & Melinda Gates Foundation expand commitments to improve access to vaccines in Africa

Aspen, CEPI and the Bill & Melinda Gates Foundation expand commitments to improve access to vaccines in Africa

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)



ASPEN, CEPI AND THE BILL & MELINDA GATES FOUNDATION EXPAND COMMITMENTS TO IMPROVE
ACCESS TO VACCINES IN AFRICA


On 31 August 2022 Aspen announced that:
 -  an agreement had been reached with the Serum Institute of India Pvt Ltd (“Serum Institute”) which
    provided Aspen with a license to the enabling know how, allowing its South African manufacturing
    operations to manufacture, market and distribute four routine vaccines in Africa; and
 -  Aspen had been negotiating the receipt of grant funding from each of the Bill & Melinda Gates
    Foundation (“the Gates Foundation”) and the Coalition for Epidemic Preparedness Innovations
    (“CEPI”) to support African regional manufacturing capacity for an affordable supply of vaccines.

Aspen now has pleasure in confirming that it has concluded a set of agreements with the Gates Foundation
and CEPI to receive the USD30 million funding to support its capabilities to manufacture lifesaving routine
and outbreak vaccines for Africa.

The new funding from CEPI and the Gates Foundation, which includes USD15 million from each
organization, will support a ten-year agreement between Aspen and Serum Institute that aims to expand
the supply and sourcing of affordable vaccines manufactured in Africa.

Through the partnership with Serum Institute, Aspen will manufacture and distribute four routine vaccines
in Africa — Pneumococcal, Rotavirus, Poly valent Meningococcal, and Hexavalent — with the technology
transfer activities initiating in early 2023. In addition to supporting the technology transfer of these routine
vaccines, the funding from CEPI and the Gates Foundation will help to sustain regional vaccine
manufacturing capacity at Aspen for potential future outbreak response, with the intention of securing
early access to African-produced vaccines in the event of a future public health emergency.


Durban
12 December 2022

Sponsor
Investec Bank Limited

Date: 12-12-2022 11:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.